Drug - Induced Diabetes Mellitus in Oghara, Delta State, Nigeria
Keywords:Diabetes Mellitus, Hypertension
Diabetes mellitus can result from drugs or chemicals among other causes. The drugs include anti- hypertensives and corticosteroids. And considering that diuretics and diuretic-containing anti- hypertensive formulations works better in blacks, these drugs are prescribed extensively; therefore, drug-induced diabetes maybe frequent in our environment. Three patients with drug-induced diabetes are reported in this case series. All were on high doses of thiazide diuretic drugs and beta-blockers. Strategies to reduce the risk of drug-induced diabetes mellitus are suggested.
Mohan LR, Mohan V. Drug-induced diabetes mellitus. J Assoc Physicians India 1997;45:876–9.
Nielsen S, Schmitz A, Knudsen RE, Dellerup J, Mogensen CE. Enalapril versus bendrofluazide in type 2 diabetic patients with hypertension. Post grad Med J 1996; 76 :263–8.
Akinkugbe OO( ed. ) In : Expert Committee on Non- communicable Diseases in Nigeria. Series 1, Lagos, Spectrum Books Pub lications Ltd. 1992; p. 3 – 49.
Elliot WJ. An individualized approach to the hypertensive patient with renal disease : six illustrative cases. J Clin Pharmacol 1995; 35 : 98 – 102.
Wokoma FS. Diabetes and hypertension in Africa–anoverview.DiabInt2002;12(2 ) : 36–8.
Elliot WJ, Meyer PN. Incident diabetes in clinical trails of anti-hypertensive drugs : a network meta-analysis. Lancet 2007; 369 : 201 –7.
Salako LA. Hypertension in Africa and effectiveness of its management with various classes of anti-hypertensive drugs in different socio-economic and cultural environments. Clin Exp Hyperten 1993; 15 : 997 – 1004
Ferner RE. Drug-induced diabetes. Clin Endocrinal Metab 1992; 6 : 849 – 66 .
Ferriere M, Bringer J, Richard M, Jaffiol C, Mirouze J. Effect of ACE-inhibition on glucose metabolism. Horm Metab Res `1990; 22:65–9.
How to Cite
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
The data collected from registered and non-registered users of this journal falls within the scope of the standard functioning of peer-reviewed journals. It includes information that makes communication possible for the editorial process; it is used to informs readers about the authorship and editing of content; it enables collecting aggregated data on readership behaviors, as well as tracking geopolitical and social elements of scholarly communication.
This journal’s editorial team uses this data to guide its work in publishing and improving this journal. Data that will assist in developing this publishing platform may be shared with its developer Public Knowledge Project in an anonymized and aggregated form, with appropriate exceptions such as article metrics. The data will not be sold by this journal or PKP nor will it be used for purposes other than those stated here. The authors published in this journal are responsible for the human subject data that figures in the research reported here.
Those involved in editing this journal seek to be compliant with industry standards for data privacy, including the European Union’s General Data Protection Regulation (GDPR) provision for “data subject rights” that include (a) breach notification; (b) right of access; (c) the right to be forgotten; (d) data portability; and (e) privacy by design. The GDPR also allows for the recognition of “the public interest in the availability of the data,” which has a particular saliency for those involved in maintaining, with the greatest integrity possible, the public record of scholarly publishing.